Company Filing History:
Years Active: 2023
Title: Verena Aumiller: Innovator in Nucleic Acid Research
Introduction
Verena Aumiller is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of nucleic acid research, particularly in the context of diseases associated with complement component C3. Her innovative work has the potential to impact the treatment and prevention of various medical conditions.
Latest Patents
Verena Aumiller holds a patent for "Nucleic acids for inhibiting expression of C3 in a cell." This invention relates to nucleic acid products that interfere with the gene expression of complement component C3. The nucleic acids are designed for use in the treatment, prevention, or reduction of risk for diseases such as C3 Glomerulopathy, Paroxysmal Nocturnal Hemoglobinuria, and Lupus nephritis, among others. She has 1 patent to her name.
Career Highlights
Aumiller is currently associated with Silence Therapeutics GmbH, where she continues her research and development efforts. Her work is focused on advancing therapeutic options for patients suffering from complement component C3 associated diseases.
Collaborations
Some of her notable coworkers include Lucas Bethge and Judith Hauptmann, who contribute to the collaborative environment at Silence Therapeutics GmbH.
Conclusion
Verena Aumiller is a key figure in the field of nucleic acid research, with a focus on innovative solutions for serious health conditions. Her contributions are paving the way for new therapeutic approaches that could benefit many patients in need.